Dual-pathway inhibitory dysfunction in schizophrenia: MEG and behavioral markers for risk stratification. Han Y, Du Y, Xia Y, Hua L, et al. J Psychiatry Neurosci 2026;51:1-14.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Han Y, Du Y, Xia Y, Hua L, et al. Dual-pathway inhibitory dysfunction in schizophrenia: MEG and behavioral markers for risk stratification. J Psychiatry Neurosci 2026;51:1-14.
PMID: 42159174